INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $55,251 | -34.4% | 262,473 | -50.1% | 0.00% | – |
| Q1 2023 | $84,166 | -42.1% | 526,036 | +100.7% | 0.00% | – |
| Q4 2022 | $145,487 | -53.4% | 262,138 | -0.1% | 0.00% | – |
| Q3 2022 | $312,000 | +86.8% | 262,526 | -0.5% | 0.00% | – |
| Q2 2022 | $167,000 | -44.3% | 263,878 | +0.2% | 0.00% | – |
| Q1 2022 | $300,000 | +29900.0% | 263,467 | +35028.9% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 750 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 750 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 750 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -100.0% | 750 | -100.0% | 0.00% | -100.0% |
| Q1 2018 | $7,535,000 | +3.4% | 3,588,249 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $7,284,000 | +1987.1% | 3,588,249 | +1513.6% | 0.00% | – |
| Q2 2017 | $349,000 | -78.3% | 222,373 | -81.3% | 0.00% | – |
| Q4 2016 | $1,605,000 | -10.3% | 1,188,976 | +3.7% | 0.00% | – |
| Q3 2016 | $1,789,000 | +23.8% | 1,146,500 | +5.5% | 0.00% | – |
| Q2 2016 | $1,445,000 | -88.4% | 1,086,500 | -54.1% | 0.00% | -100.0% |
| Q1 2016 | $12,468,000 | -32.5% | 2,365,825 | +0.5% | 0.00% | 0.0% |
| Q4 2015 | $18,472,000 | +4.3% | 2,353,167 | +12.2% | 0.00% | -33.3% |
| Q3 2015 | $17,714,000 | -25.2% | 2,096,367 | -3.1% | 0.00% | 0.0% |
| Q2 2015 | $23,695,000 | -29.6% | 2,163,948 | -10.1% | 0.00% | -25.0% |
| Q1 2015 | $33,663,000 | -38.7% | 2,407,942 | -25.9% | 0.00% | -42.9% |
| Q4 2014 | $54,913,000 | +21.3% | 3,251,242 | -3.6% | 0.01% | +16.7% |
| Q3 2014 | $45,278,000 | -28.8% | 3,373,942 | -32.4% | 0.01% | -33.3% |
| Q2 2014 | $63,575,000 | +18.3% | 4,990,187 | +10.4% | 0.01% | +28.6% |
| Q1 2014 | $53,726,000 | -1.5% | 4,518,612 | +14.5% | 0.01% | -12.5% |
| Q4 2013 | $54,521,000 | -53.2% | 3,947,866 | -40.8% | 0.01% | -55.6% |
| Q3 2013 | $116,382,000 | -0.2% | 6,669,469 | -7.0% | 0.02% | -5.3% |
| Q2 2013 | $116,578,000 | – | 7,174,041 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |